The pharmacogenomics market share will rise with a CAGR of 8.8 % by the year 2023.

With the increasing demand for diagnostic tests led by the growing emphasis of patients on pre-diagnosis treatments, increasing genetic disorders & mutational diseases, the market is expanding rapidly. The government initiatives and investments in R&D pr...